Patent · US Active

Treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain

US8404642B2 · kind B2 · utility

6Cited by

0References

39Claims

0Family size

Assignee

NsGene A/S · DK

Inventors

Jesper Roland Jørgensen · Copenhagen, DK
Lars Ulrik Wahlberg
Teit E. Johansen · Ringsted, DK

Key dates

Filing date	Oct 3, 2011
Grant date	Mar 26, 2013
Priority date	—
Expiry date	Oct 3, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2035/126
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of Meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain. In a preferred embodiment the disorder to be treated is allodynia, and hyperalgesia, more preferably allodynia including thermal and tactile allodynia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.